Active Research Studies

Thank you for your interest in our research studies! To see more information about the study you're interested in, please click on "More Info" located in each row.

Study Name

Medication Involved

Currently Enrolling

 

COllaborative, National QUality and Efficacy Registry for Tracking Disease Progression in Systemic Sclerosis (Scleroderma) Patients (CONQUER)

NO YES MORE INFO
Evaluating X-Chromosome Inactivation Maintenance in a Cross-sectional Cohort of Patients with Systemic Sclerosis NO YES

MORE INFO

A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis (HORIZON)

YES NO MORE INFO
A Phase 2/3, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of belimumab administered subcutaneously in adults with systemic sclerosis associated interstitial lung disease (BLISSc-ILD) YES YES MORE INFO
A Single Center Study of Patients with Autoimmune Diseases Receiving an Autologous Fully-Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CARTIMMUNE) YES YES MORE INFO
SCTC White Paper Initiative     MORE INFO